Successful use of hemoperfusion in phenobarbitone poisoning.

Ther Apher Dial

Department of Nephrology, Sri Devaraj Urs Academy of Higher Education and Research, Kolar, Karnataka, India.

Published: December 2024

Download full-text PDF

Source
http://dx.doi.org/10.1111/1744-9987.14201DOI Listing

Publication Analysis

Top Keywords

successful hemoperfusion
4
hemoperfusion phenobarbitone
4
phenobarbitone poisoning
4
successful
1
phenobarbitone
1
poisoning
1

Similar Publications

Hemadsorption with CytoSorb®: focus on the latest experiences in cardiac surgery patients.

J Artif Organs

December 2024

Division of Cardiology, Ospedale Civile Maggiore Borgo Trento, Piazzale Stefani, Verona, (VR), Italy.

Cardiac surgery patients are potentially exposed to an acute inflammatory host response with a huge release of both pro- and anti-inflammatory cytokines both through intrinsic (e.g., tissue damage, endothelial injury) and extrinsic (e.

View Article and Find Full Text PDF

Extracorporeal blood purification (ECBP) has become a popular treatment option for non-steroidal anti-inflammatory drug (NSAID) toxicity in small animals. However, challenges arise when using ECBP for small dogs and cats because the priming volume required by most machine-based ECBP platforms might be excessive, leading to cardiovascular instability if a blood prime is not used. This report describes the successful use of manual carbon hemoperfusion (MCHP) to reduce plasma meloxicam levels in a cat following an inadvertent overdose and its use in a dog following suspected ibuprofen ingestion.

View Article and Find Full Text PDF

Successful use of hemoperfusion in phenobarbitone poisoning.

Ther Apher Dial

December 2024

Department of Nephrology, Sri Devaraj Urs Academy of Higher Education and Research, Kolar, Karnataka, India.

View Article and Find Full Text PDF

Hemoperfusion (HP) is employed to modulate cytokine storms in severe coronavirus disease 2019 (COVID-19) patients, requiring careful attention for success and safety. Therefore, we investigated whether our care bundles could enhance HP performance. We conducted a retrospective cohort study on adult patients (≥20 years old) with severe COVID-19 pneumonia.

View Article and Find Full Text PDF

Background: It is imperative to note that integrated system continuous renal replacement therapy (CRRT) necessitates a sophisticated and costly apparatus, potentially limiting its availability within resource-limited settings. The introduction of a separated system for continuous veno-venous hemofiltration (CVVH), characterized by uncomplicated setup procedures with a hemoperfusion machine, holds promise as a feasible alternative to CRRT for critically ill patients with acute kidney injury (AKI).

Methods: We aimed to retrospectively analyze the effectiveness and safety of separated CRRT applied from a hemoperfusion machine in critically ill patients with AKI during the January 2015 to December 2021 period.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!